264 results on '"Lechner, Katharina"'
Search Results
2. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
3. Autorinnen und Autoren
4. Arterielle Hypertonie
5. CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy
6. Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
7. Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.
8. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
9. Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
10. Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial
11. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
12. Cardiometabolic and immune response to exercise training in patients with metabolic syndrome: retrospective analysis of two randomized clinical trials
13. Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
14. Personalisierte Behandlungskonzepte bei arterieller Hypertonie
15. Kardiovaskuläre Manifestationen von COVID-19
16. Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes
17. Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance
18. Großquellen der Kluft- und Karstgrundwasserleiter im Karwendel (Nördliche Kalkalpen, Tirol): Beitrag zum Verständnis hydrogeologischer Prozesse zur Sicherung der zukünftigen Trinkwasserversorgung
19. A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma
20. Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19
21. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients
22. Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial
23. Should We Use Genetic Scores in the Determination of Treatment Strategies to Control Dyslipidemias?
24. Supplementary Methods, Supplementary References, Supplementary Figure 1, Supplementary Tables 1-3 from First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors
25. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients
26. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
27. Phase 1 Study of CD19 Targeted CD28 Costimulatory Agonist in Combination with Glofitamab to Enhance T Cell Effector Function in Relapsed/Refractory B Cell Lymphoma
28. CD19 4-1BBL (RO7227166) a Novel Costimulatory Bispecific Antibody Can be Safely Combined with the T-Cell-Engaging Bispecific Antibody Glofitamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
29. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
30. Obesity and cardiovascular disease: beyond body weight and energy balance
31. Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial
32. Abstract 15055: Walnut-Enriched Diet Beneficially Alters Gut Microbiome in Healthy Caucasian Subjects
33. So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung
34. Re-evaluating low-carbohydrate diets and mortality
35. Weight-gain Independent Effect of Mirtazapine on Fasting Plasma Lipids in Healthy Men
36. Abstract 2048: In vitro and in vivo characterization of non-oncolytic engineered arenavirus vectors for cancer immunotherapy
37. Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial
38. Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial
39. Low-Carb-Diäten – die unvoreingenommene und evidenzbasierte Betrachtung ist überfällig
40. Personalisierte Behandlungskonzepte bei arterieller Hypertonie
41. Ernährungsempfehlungen bei Typ-2-Diabetes: Grundlegendes Umdenken
42. Phase Ib study of BET inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
43. Gemcitabine Treatment of Rat Soft Tissue Sarcoma with Phosphatidyldiglycerol-Based Thermosensitive Liposomes
44. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
45. The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled Trial
46. Abstract LB104: Dose-Finding/Expansion Phase Ib Study to Evaluate the Safety and Activity of BET Inhibitor RO6870810 (RO) and Atezolizumab (A) in Patients (pts) with Advanced Ovarian Cancer (OC) or Triple Negative Breast Cancer (TNBC)
47. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic riskfactors in HFpEF patients
48. Inflammation and Cardiovascular Disease: The Future
49. Turning back the clock on aging? A perspective on selected mechanisms and therapeutic avenues [Den alterungsprozess verlangsamen? Eine perspektive über ausgewählte mechanismen und therapeutische möglichkeiten]
50. Intersektorale Kooperation im österreichischen Gesundheitswesen - die Zusammenarbeit des Krankenhauses mit vor- und nachgelagerten Versorgungsbereichen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.